Related Experiment Video
Updated: Jan 21, 2026
![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
10:33
Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
Published on: April 25, 2025
1.1K
The Tumor Microenvironment Innately Modulates Cancer Progression.
Dominique C Hinshaw1, Lalita A Shevde2,3
1Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.
Cancer Research
|July 28, 2019
Summary
Cancer cells reshape the tumor microenvironment (TME) by interacting with immune cells. Understanding this cross-talk is key to developing targeted therapies for better patient outcomes.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Tumor development involves dynamic interactions between cancer cells and the surrounding stroma.
- Cancer cells secrete factors that reprogram stromal cells, influencing tumor survival and progression.
- Immune cells are key components of the tumor stroma, actively participating in tumor progression.
Purpose of the Study:
- To elucidate the role of immune cells within the tumor microenvironment (TME).
- To understand the cross-talk between cancer cells and immune cells in fostering tumor growth and metastasis.
- To highlight the potential for targeting TME components for improved cancer therapeutics.
Main Methods:
- Review of current literature on tumor microenvironment composition and function.
- Analysis of immune cell subsets (innate and adaptive) within the TME.
- Examination of molecular signaling pathways involved in cancer-immune cell interactions.
Main Results:
- Both innate immune cells (macrophages, neutrophils, dendritic cells, etc.) and adaptive immune cells (T cells, B cells) contribute to tumor progression.
- Cancer cells functionally sculpt the TME through secreted factors, reprogramming stromal and immune cells.
- Complex cross-talk between cancer and immune cells creates an environment conducive to tumor growth and metastasis.
Conclusions:
- Immune cells play a critical, often pro-tumorigenic, role within the tumor microenvironment.
- Understanding the dialogue between cancer cells and immune cells is essential for therapeutic development.
- Targeting multiple TME components simultaneously holds promise for enhancing therapeutic efficacy and patient outcomes.
Related Concept Videos
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
03:03mTOR Signaling and Cancer Progression
4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.7K
02:40Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K